| |
| |
|
| Insider
Information: |
Steinhart Richard I |
| Relationship: |
Chief Financial Officer |
| City: |
New Canaan |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
44,898 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$198,992 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,898 |
|
|
| Total
Value |
$198,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TG Therapeutics Inc |
TGTX |
Director |
2007-01-30 |
5,633 |
2007-01-30 |
0 |
Premium* |
|
|
Strata Skin Sciences Inc |
SSKN |
Chief Financial Officer |
2013-08-05 |
25,000 |
2010-08-12 |
0 |
Premium* |
|
|
Atossa Genetics Inc |
ATOS |
Director |
2014-05-06 |
0 |
2014-03-01 |
0 |
Premium* |
|
|
Actinium Pharmaceuticals Inc |
ATNM |
Director |
2018-03-06 |
9,500 |
2016-04-14 |
0 |
Premium* |
|
|
Bioxcel Therapeutics Inc |
BTAI |
Chief Financial Officer |
2024-04-04 |
4,765 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-04-04 |
4 |
AS |
$2.64 |
$2,817 |
D/D |
(1,069) |
4,765 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
5,834 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
3,584 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
3,063 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
2,542 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
2,021 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-05-15 |
4 |
AS |
$27.17 |
$135,864 |
D/D |
(5,000) |
1,500 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
6,500 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
AS |
$19.50 |
$40,638 |
D/D |
(2,084) |
1,500 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,084 |
3,584 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
AS |
$48.15 |
$180,563 |
D/D |
(3,750) |
1,500 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
OE |
$5.55 |
$20,813 |
D/D |
3,750 |
5,250 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-03 |
4 |
B |
$5.20 |
$2,600 |
D/D |
500 |
1,500 |
2.66 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-11-30 |
4 |
B |
$5.00 |
$2,500 |
D/D |
500 |
1,000 |
2.66 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-11-29 |
4 |
B |
$5.00 |
$2,500 |
D/D |
500 |
500 |
2.66 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Director |
– • – |
2018-03-06 |
4 |
A |
$0.50 |
$3,500 |
D/D |
7,000 |
9,500 |
0 |
- |
|
| ATNM |
Actinium Pharmaceuticals ... |
Director |
– • – |
2016-04-14 |
4 |
B |
$2.01 |
$5,025 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| ATOS |
Atossa Genetics Inc |
Director |
– • – |
2014-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,728) |
0 |
0 |
- |
|
| ATOS |
Atossa Genetics Inc |
Director |
– • – |
2014-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,728 |
22,728 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
Chief Financial Officer |
• – – |
2013-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
Chief Financial Officer |
• – – |
2013-06-25 |
4 |
B |
$0.81 |
$2,427 |
D/D |
3,000 |
4,000 |
2.66 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
Chief Financial Officer |
• – – |
2010-08-12 |
4 |
B |
$6.32 |
$6,320 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2007-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,633 |
5,633 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
